Gene · 7398
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resource potential mapping of bifacial photovoltaic systems in India. | iScience | 2023 | 37829198 | PubTator, text mining | PubMed |
| FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma. | Eur J Med Res | 2023 | 37821996 | PubTator, text mining | PubMed |
| USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation. | Cell Death Dis | 2023 | 37821462 | PubTator, text mining | PubMed |
| USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis. | J Clin Invest | 2023 | 37788092 | PubTator, text mining | PubMed |
| Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. | Cell Commun Signal | 2023 | 37770930 | PubTator, text mining | PubMed |
| Non-Canonical Amino Acids in Analyses of Protease Structure and Function. | Int J Mol Sci | 2023 | 37762340 | PubTator, text mining | PubMed |
| Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms. | J Transl Med | 2023 | 37752518 | PubTator, text mining | PubMed |
| Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer. | Cell Death Discov | 2023 | 37749082 | PubTator, text mining | PubMed |
| Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway. | Cancer Cell Int | 2023 | 37743467 | PubTator, text mining | PubMed |
A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer. | Cell Discov | 2023 | 37714834 | PubTator, text mining | PubMed |
| Amino acid metabolism in health and disease. | Signal Transduct Target Ther | 2023 | 37699892 | PubTator, text mining | PubMed |
| Necroptosis-related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer. | Cancer Rep (Hoboken) | 2023 | 37681751 | PubTator, text mining | PubMed |
| A new wave of innovations within the DNA damage response. | Signal Transduct Target Ther | 2023 | 37679326 | PubTator, text mining | PubMed |
| USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target. | Cell Death Discov | 2023 | 37679322 | PubTator, text mining | PubMed |
| Branched-chain amino acids catabolism and cancer progression: focus on therapeutic interventions. | Front Oncol | 2023 | 37637065 | PubTator, text mining | PubMed |
| Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin. | Int J Mol Sci | 2023 | 37628997 | PubTator, text mining | PubMed |
| The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis. | Biomolecules | 2023 | 37627314 | PubTator, text mining | PubMed |
| BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1. | Cell Death Discov | 2023 | 37626049 | PubTator, text mining | PubMed |
| The deubiquitinase Leon/USP5 interacts with Atg1/ULK1 and antagonizes autophagy. | Cell Death Dis | 2023 | 37607937 | PubTator, text mining | PubMed |
| FGF13A interacts with NPM1 and UBF and inhibits the invasion of bladder cancer cells. | Biochem Biophys Res Commun | 2023 | 37603967 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7398/papers?page=10